An interventional study of Pre-diabetes Virtual Community in Prediabetes, sponsored by Third Affiliated Hospital, Sun Yat-Sen University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.
Sponsored by Third Affiliated Hospital, Sun Yat-Sen University · Not applicable, Interventional, and Prevention
This study builds upon the previously developed virtual health community platform, aiming to address the group characteristics and psychological traits of prediabetic patients. By employing intervention mapping to construct a group interaction management model, it seeks to develop a mobile platform integrating "gamified knowledge acquisition and motivation", "immersive lifestyle practice experiences", and "sustained community interaction management". The primary focus is on fostering patients' continuous and proactive engagement. Subsequently, a single-arm controlled trial will validate the model's efficacy, aiming to address the health management challenges faced by China's substantial prediabetic population. This initiative seeks to provide theoretical foundations and practical support for primary prevention strategies targeting other chronic diseases and at-risk cohorts.
999 studies on the registry are indexed under Prediabetic State; 238 are open to participants now.
This study's enrollment of 60 is close to the median of 65 across 844 interventional studies indexed under Prediabetic State.
Browse Prediabetic State studies →Third Affiliated Hospital, Sun Yat-Sen University is the lead sponsor of 130 studies on the registry; 34 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Pre-diabetes Virtual Community
By collecting general information, physical measurements, glucose and lipid metabolism indicators, dietary habits, and exercise routines from prediabetic patients, these details are input into the virtual community programme for prediabetes. The virtual community evaluates the input data, alerts healthcare professionals to patients requiring immediate intervention, and provides guidance for the forthcoming week regarding diet, exercise, and other health aspects (including dietary and exercise advice for prediabetic patients), alongside risk alerts.
Physical activity
Participants self-reported their daily physical activity levels, with the International Physical Activity Questionnaire (IPAQ) used to assess the frequency, duration, and intensity (i.e., light, moderate, and vigorous activities) of physical activity across different domains (work, transportation, household, and leisure) over the past 7 days.
Time frame: From enrolment to the conclusion of the study, 2 weeks.
Diet
Participants self-reported their daily meal consumption through periodic 24-hour dietary recalls or food diaries. These data were then used to calculate the Planetary Health Diet Score, providing a weekly assessment of diet quality.
Time frame: From enrolment to the conclusion of the study, 2 weeks.
Fasting blood glucose
Time frame: From enrolment to the conclusion of the study, 2 weeks.
Two-hour postprandial blood glucose
Time frame: From enrolment to the conclusion of the study, 2 weeks.
Task Completion Rate
Task Completion Rate is defined as the percentage of target users who successfully met the task criteria within the specified time frame and user scope. It directly reflects the implementation efficiency of the intervention and user adherence (e.g., dietary logging rate, exercise plan execution rate). Formula: Task Completion Rate = (Number of users who successfully completed the task / Total number of target users) × 100%.
Time frame: From enrolment to the conclusion of the study, 2 weeks.
Body Mass Index (BMI)
Time frame: From enrolment to the conclusion of the study, 2 weeks.
Total cholesterol
Time frame: On the first day of enrolment, at the conclusion of the intervention two weeks later.
Triglycerides
Time frame: On the first day of enrolment, at the conclusion of the intervention two weeks later.
High-density lipoprotein cholesterol (HDL-C)
Time frame: On the first day of enrolment, at the conclusion of the intervention two weeks later.
Low-density lipoprotein cholesterol (LDL-C)
Time frame: On the first day of enrolment, at the conclusion of the intervention two weeks later.
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Third Affiliated Hospital, Sun Yat-Sen University